NTRA's logo.
Ticker Symbol: NTRA

Natera Inc

$115.00 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001604821

Company Profile

Naterais a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas. It offers proprietary genetic testing services to inform obstetricians, transplant physicians, oncologists, and cancer researchers, including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform.

Sector: Health Care and Social Assistance
Industry: Medical Laboratories
Standard Industrial Classification Code (SIC code): 8071
Address: N/A
CEO: N/A
Tags:
  • Health Technology
  • Biotechnology
  • Health Services
  • Medical/Nursing Services
  • Health Care and Social Assistance
  • Medical Laboratories

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $43.95
Change: $0.27 ( 0.62%)
Days Range: $43.02 - $43.99
Beta: 1.08
52wk. High: $63.00
52wk. Low: $34.00
Ytd. Change 9.36%
50 Day Moving Average: $47.90
200 Day Moving Average: $50.16
Shares Outstanding: 114601688

Valuation

Market Cap: 503.7B
PE Ratio: -9.16
EPS (TTM): -4.8

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A